Abstract
Tumor necrosis factor (TNF) is a cytokine with well known anticancer properties and is being utilized as anticancer agent for the treatment of patients with locally advanced solid tumors. However, TNF role in cancer biology is debated. In fact, in spite of the wealth of evidence supporting its antitumor activity, the cascade of molecular events underlying TNF-mediated tumor regression observed in vivo is still incompletely elucidated. Furthermore, some preclinical findings suggest that TNF may even promote cancer development and progression. With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Keywords: Tumor necrosis factor, TNF, cancer, biology, therapy, chemotherapeutic agents, cancer biotherapy, Coley's toxin, TNF PATHWAY, TNF-converting enzyme, TACE, (DISC), transcription factors, (SODD), programmedcell-death, apoptosis, FLICE, ceramide, ANTICANCER, cathepsin-B, murine fibrosarcoma, haemorrhagic necrosis, thromosis, pro-coagulant tissue factor, NOS, antineoplastic agents, malignant cells, protein kinase-C, carcinogenesis, angiogenesis, Cancer anorexia-cachexia syndrome, single nucleotide polymorphisms, isolated limb perfusion, isolated hepatic perfusion, ANTI-TNF THERAPY, TNF-antagonists, TNF Muteins, NFkB Pathway, NFkB, proapoptotic factors, NSAID, PKB/Akt
Current Medicinal Chemistry
Title: The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Volume: 17 Issue: 29
Author(s): L. Bertazza and S. Mocellin
Affiliation:
Keywords: Tumor necrosis factor, TNF, cancer, biology, therapy, chemotherapeutic agents, cancer biotherapy, Coley's toxin, TNF PATHWAY, TNF-converting enzyme, TACE, (DISC), transcription factors, (SODD), programmedcell-death, apoptosis, FLICE, ceramide, ANTICANCER, cathepsin-B, murine fibrosarcoma, haemorrhagic necrosis, thromosis, pro-coagulant tissue factor, NOS, antineoplastic agents, malignant cells, protein kinase-C, carcinogenesis, angiogenesis, Cancer anorexia-cachexia syndrome, single nucleotide polymorphisms, isolated limb perfusion, isolated hepatic perfusion, ANTI-TNF THERAPY, TNF-antagonists, TNF Muteins, NFkB Pathway, NFkB, proapoptotic factors, NSAID, PKB/Akt
Abstract: Tumor necrosis factor (TNF) is a cytokine with well known anticancer properties and is being utilized as anticancer agent for the treatment of patients with locally advanced solid tumors. However, TNF role in cancer biology is debated. In fact, in spite of the wealth of evidence supporting its antitumor activity, the cascade of molecular events underlying TNF-mediated tumor regression observed in vivo is still incompletely elucidated. Furthermore, some preclinical findings suggest that TNF may even promote cancer development and progression. With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Export Options
About this article
Cite this article as:
Bertazza L. and Mocellin S., The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology, Current Medicinal Chemistry 2010; 17 (29) . https://dx.doi.org/10.2174/092986710793176339
DOI https://dx.doi.org/10.2174/092986710793176339 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular Effects of Antiarrhythmic Drugs and the Roles of K+ Channels
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Angiotensin, The Hormone to be Blocked by Antithypertensive Drugs, and Perhaps Why They Dont Work
Current Vascular Pharmacology Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Key Points in Management for Severe Community-Acquired Pneumonia
Current Respiratory Medicine Reviews Endoplasmic Reticulum Stress and Atherosclerosis
Current Hypertension Reviews Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Pathogenesis of Diabetic Retinopathy and Diabetic Macular Edema and Enzyme Inhibition
Current Enzyme Inhibition A Review on Skin Targeted Delivery of Bioactives as Ultradeformable Vesicles: Overcoming the Penetration Problem
Current Drug Targets Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
Current Cardiology Reviews New Approaches to Endothelin Receptor Antagonist-Bosentan
Letters in Organic Chemistry Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools
Protein & Peptide Letters Safety of Spinal Anesthesia in a Patient with Achondroplasia for Cesarean Section
Current Drug Safety Characterization of a New Impurity in Metaraminol Bitartrate for Injection by 2D HPLC-Q/TOF-MS, Chemical Synthesis and NMR
Current Pharmaceutical Analysis Drugs and Aggression
Recent Patents on CNS Drug Discovery (Discontinued) The Future of Angiotensin II Inhibition in Cardiovascular Medicine
Current Drug Targets - Cardiovascular & Hematological Disorders Editorial [Hot Topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Current Pharmaceutical Design Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms
Endocrine, Metabolic & Immune Disorders - Drug Targets Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted Antioxidants
Infectious Disorders - Drug Targets COVID-19: An Opinion of Prevention and Dietary Based Management Hypothesis
Coronaviruses